Molecular profiling of breast cancer: portraits but not physiognomy

AUTOR(ES)

Brenton, James D

FONTE

BioMed Central

RESUMO

Breast cancers differ in response to treatment and may have a divergent clinical course despite having a similar histopathological appearance. New technology using DNA microarrays provides a systematic method to identify key markers for prognosis and treatment response by profiling thousands of genes expressed in a single cancer. Microarray profiling of 38 invasive breast cancers now confirms striking molecular differences between ductal carcinoma specimens and suggests a new classification for oestrogen-receptor negative breast cancer. Future approaches will need to include methods for high-throughput clinical validation and the ability to analyze microscopic samples.

Documentos Relacionados

• Molecular biology of breast cancer metastasis: Inflammatory breast cancer: clinical syndrome and molecular determinants
• Expression profiling to predict outcome in breast cancer: the influence of sample selection
• The pathology of familial breast cancer: Immunohistochemistry and molecular analysis
• Websites on screening for breast cancer: Not all advocacy groups receive industry funding
• Breast Cancer: A Multidisciplinary Approach